Newsletter Edition #384 [The Files In-Depth]
Readers,
One of the most powerful actors in global health - the Global Fund to Fight AIDS, Tuberculosis and Malaria - is choosing its next leader.
This process has implications not just for these three diseases, but also in the larger scheme of how money flows in global health, and how decisions are made upstream, and their eventual impact downstream in countries. To this, add another layer of the overall reforms in the sector, and this becomes a key moment in the life of the institution.
Today's analysis has been reported by my colleague Merlin Ince. Ince is a sociologist from South Africa, and his interests include global health policy and inequality, among other areas. He is a part of our annual fellowship program this year.
We hope you find this piece insightful in contextualizing the leadership race in the broader transition in the field.
Geneva Health Files offers value to our readers who are experts in global health. Tracking global health policy-making in Geneva is tough and expensive, without institutional support. For six years, we have provided you with the information and tools that directly contribute to your work in the field. We rely on our readers who value news they can use.
By becoming a paying subscriber you make our work possible and help us gather, report and synthesise global health intelligence.
Thank you for your engagement.
Best,
Priti
Priti Patnaik, Founder & Publisher, Geneva Health Files
Feel free to write to us: genevahealthfiles@gmail.com ; Find us on BlueSky, Instagram and Linkedin.
Presenting our weekly in-depth analysis on global health that captures the big picture and the nuances like no one else does. This is an exclusive edition for our subscribers.
I. STORY OF THE WEEK:
Equal Votes, Unequal Voice? The Global Fund's Leadership Test
By Merlin Ince
Priti Patnaik contributed to this story
The selection of a new Executive Director
Weeks from now in October 2026, the Global Fund's Board will meet in Geneva to choose the institution's next Executive Director. The leadership transition at the Fund occurs at a time when global health financing has essentially been reset on account of drastic budget cuts that are estimated to have claimed more than 750 000 lives across 93 countries.
The Board's 20 voting seats are split evenly between donor countries and the countries where HIV, TB and malaria cause the most illness and death. That structure was built to give both groups equal say in decisions such as leadership selection. But before the Board votes, a nomination committee draws up the shortlist it will choose from, and every candidate named publicly so far is a United States national. (The final list is not public yet.)
A shortlist assembled before the vote raises the question: where power inside the Global Fund actually sits, and whether the countries carrying the heaviest burden of these diseases have a real hand in choosing who leads the institution built to serve them.
